改善帕克利塔塞尔的输送:以PEGylated聚聚乙烯为基础的纳米载体的体外和体外表征
Fuwu Zhang1, Shiyi Zhang, Stephanie F Pollack
1Departments of Chemistry, Chemical Engineering, and Materials Science and Engineering, ‡Laboratory for Synthetic-Biologic Interactions, and §Texas A&M Institute for Preclinical Studies, Texas A&M University , College Station, Texas 77842, United States.
Journal of the American Chemical Society
|January 29, 2015
概括
新型可生物降解的纳米颗粒有效地提供高度的帕克利塔塞尔 (PTX) 持续释放,显示出治疗骨髓瘤肺转移的前景.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 纳米材料为治疗疾病提供局部,持续的药物输送.
- 开发出了可生物降解的基于聚聚的纳米粒子 (和交联的状纳米粒子 - - SCKs).
研究的目的:
- 设计和描述新型纳米结构,用于高度,持续的帕克利塔克塞尔 (PTX) 输送.
- 调查这些纳米疗法在骨肉瘤肺转移治疗中的结构功能关系.
主要方法:
- 两性块接种聚合物 (PEBP-b-PBYP-g-PEG) 用于制造带PTX的和SCKs.
- 评估了物理化学特征,药物负载,释放动力学和体外/体内疗效.
主要成果:
- 与单独使用药物 (<2.0微克/毫升) 相比,纳米颗粒实现了高PTX悬浮 (4.8毫克/毫升).
- 在SCKs的交叉链接使PTX的持续释放半衰期翻了一番.
- 在体外研究表明,Taxol对骨髓瘤细胞系的疗效与Taxol相似;在体内研究评估了内内传递和药理动力学.
结论:
- 新型PTX载和SCK显示了持续药物释放的潜力.
- 纳米粒子结构显著影响药物释放动力学和治疗结果.
- 这些纳米疗法在局部治疗骨肉瘤肺转移方面表现有前途.
相关概念视频
Site-Targeted Drug Delivery Systems: Polymeric Carriers
132
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
132
Drugs that Stabilize Microtubules
2.9K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K


